Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00570 TRAD CHI MED
RTNominal down4.280 -0.020 (-0.465%)
Others

26/10/2018 09:06

Trad Chi Med (00570) says two more drugs added to EDL

[ET Net News Agency, 26 October 2018] China Traditional Chinese Medicine Holdings Co.
Limited (00570) said, other than the eight exclusive products of the company that are in
the Essential Drug List (EDL), two more exclusive products that were included in the
update 2018 EDL in September.
The newly added products are Carapacis Trionycis Bdus and Jinye Baidu Granules,
manufactured by its subsidiary Sinopharm Group Zhonglian Pharmaceutical. The board
believes that these new EDL products will have greater growth potentials and
profitability. (KL)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.